Literature DB >> 6768731

Biosynthesis of heparin. Concerted action of late polymer-modification reactions.

I Jacobsson, U Lindahl.   

Abstract

The substrate specificity of O-sulfotransferases involved in the biosynthesis of heparin was studied by incubating exogenous polysaccharide acceptors with mouse mastocytoma microsomal fraction in the presence of phosphoadenylyl[35S]sulfate. Characterization of the labeled products showed that O-sulfation occurs preferentially in the vicinity of N-sulfate groups; that 2-O-sulfation of L-iduronic acid residues occurs preferentially or exclusively in the absence of a 6-O-sulfate group on adjacent D-glucosamine units; and that 6-O-sulfation of D-glucosamine residues occurs readily in the presence of 2-O-sulfate groups on adjacent L-iduronic acid units. Furthermore, structural analysis of microsomal heparin-precursor polysaccharides showed a distinct intermediate species that contained 2-O-sulfated L-iduronic acid units but essentially no 6-O-sulfate groups on the (N-sulfated) D-glucosamine residues. The results suggest that 2-O-sulfation of L-iduronic acid units is tightly coupled to the formation of these units (by 5-epimerization of D-glucuronic acid residues) and, furthermore, that both processes are completed before 6-O-sulfation of the polysaccharide molecule is initiated. D-Glucuronosyl 5-epimerization not accompanied by 2-O-sulfation occurs at a still earlier stage of polymer modification; the resulting L-iduronic acid units appear to remain nonsulfated throughout the subsequent modification reactions.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6768731

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  19 in total

1.  Biosynthesis of heparin. Relationship between the polymerization and sulphation processes.

Authors:  K Lidholt; L Kjellén; U Lindahl
Journal:  Biochem J       Date:  1989-08-01       Impact factor: 3.857

Review 2.  Structure and function of heparan sulphate proteoglycans.

Authors:  J T Gallagher; M Lyon; W P Steward
Journal:  Biochem J       Date:  1986-06-01       Impact factor: 3.857

3.  Subcellular localization of the sulphation reaction of heparan sulphate synthesis and transport of the proteoglycan to the cell surface in rat liver.

Authors:  J M Graham; D J Winterbourne
Journal:  Biochem J       Date:  1988-06-01       Impact factor: 3.857

Review 4.  Mechanism of the anticoagulant action of heparin.

Authors:  I Björk; U Lindahl
Journal:  Mol Cell Biochem       Date:  1982-10-29       Impact factor: 3.396

5.  Genetic analysis of the heparan modification network in Caenorhabditis elegans.

Authors:  Robert A Townley; Hannes E Bülow
Journal:  J Biol Chem       Date:  2011-03-24       Impact factor: 5.157

6.  Human liver N-acetylglucosamine-6-sulphate sulphatase. Catalytic properties.

Authors:  C Freeman; J J Hopwood
Journal:  Biochem J       Date:  1987-09-01       Impact factor: 3.857

7.  Biosynthesis of heparin. Use of Escherichia coli K5 capsular polysaccharide as a model substrate in enzymic polymer-modification reactions.

Authors:  M Kusche; H H Hannesson; U Lindahl
Journal:  Biochem J       Date:  1991-04-01       Impact factor: 3.857

8.  Biosynthesis of heparin. Modulation of polysaccharide chain length in a cell-free system.

Authors:  K Lidholt; J Riesenfeld; K G Jacobsson; D S Feingold; U Lindahl
Journal:  Biochem J       Date:  1988-09-01       Impact factor: 3.857

9.  Very-high-field n.m.r. studies of bovine lung heparan sulphate tetrasaccharides produced by nitrous acid deaminative cleavage. Determination of saccharide sequence, uronate composition and degrees of sulphation.

Authors:  P N Sanderson; T N Huckerby; I A Nieduszynski
Journal:  Biochem J       Date:  1984-10-15       Impact factor: 3.857

10.  Molecular distinctions between heparan sulphate and heparin. Analysis of sulphation patterns indicates that heparan sulphate and heparin are separate families of N-sulphated polysaccharides.

Authors:  J T Gallagher; A Walker
Journal:  Biochem J       Date:  1985-09-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.